Results 1 to 10 of about 1,338,396 (267)

Predilation Ballooning in High Thrombus Laden STEMIs: An Independent Predictor of Slow Flow/No-Reflow in Patients Undergoing Emergent Percutaneous Coronary Revascularization

open access: yesJournal of Interventional Cardiology, 2023
Background. Distal embolization due to microthrombus fragments formed during predilation ballooning is considered one of the possible mechanisms of slow flow/no-reflow (SF/NR).
Rajesh Kumar   +11 more
doaj   +1 more source

Acute Occlusion of the Infarct-Related Artery as a Predictor of Very Long-Term Mortality in Patients with Acute Myocardial Infarction

open access: yesCardiology Research and Practice, 2021
Aim. The survey’s aim was to examine the significance of infarct-related artery (IRA) occlusion (verified angiographically) on very long-term outcomes of patients with acute myocardial infarction, within the STEMI and NSTEMI diagnosis. Methods.
Nikola Kos   +7 more
doaj   +1 more source

Cardiovascular Disease [PDF]

open access: yesBMC Women's Health, 2004
HEALTH ISSUE: Cardiovascular disease (CVD) is the leading cause of death in Canadian women and men. In general, women present with a wider range of symptoms, are more likely to delay seeking medial care and are less likely to be investigated and treated with evidence-based medications, angioplasty or coronary artery bypass graft than men. KEY FINDINGS:
Grace, Sherry L   +3 more
openaire   +4 more sources

Declining Trend of Transapical Access for Transcatheter Aortic Valve Replacement in Patients with Aortic Stenosis

open access: yesJournal of Interventional Cardiology, 2022
Introduction. The last decade has witnessed major evolution and shifts in the use of transcatheter aortic valve replacement (TAVR) for severe aortic stenosis (AS).
Sumit Sohal   +8 more
doaj   +1 more source

Acute hyperglycemia, a rabble-rouser or innocent bystander? A prospective analysis of clinical implications of acute hyperglycemia in STE-ACS patients

open access: yesBMC Cardiovascular Disorders, 2023
Background Acute hyperglycemia is considered an independent prognosticator of both in-hospital and long-term outcomes in patients with acute coronary syndrome (ACS).
Rajesh Kumar   +13 more
doaj   +1 more source

Time to think beyond door to balloon time: significance of total ischemic time in STEMI

open access: yesThe Egyptian Heart Journal, 2021
Background Significance of total ischemic time (TIT) in the context of ST-segment elevation myocardial infarction (STEMI) is still controversial. Therefore, in this study, we have evaluate the association of TIT with immediate outcomes in STEMI patients ...
Sanam Khowaja   +9 more
doaj   +1 more source

Severe pacemaker pocket infection during the COVID-19 pandemic, transvenous lead removal

open access: yesJournal of Infection in Developing Countries, 2021
Introduction: The estimated infection rate after permanent endocardial lead implantation is between 1% and 2%. Pacemaker lead endocarditis is treated with total removal of the infected device and proper antibiotics.
Milos Dusan Babic   +9 more
doaj   +1 more source

Incidence, Predictors, and Outcomes of Acute and Subacute Stent Thrombosis after Emergency Percutaneous Coronary Revascularization with Drug-Eluting Stents: A Prospective Observational Study

open access: yesGlobal Heart, 2022
Background: Stent thrombosis (ST) remains the most feared complication of percutaneous coronary intervention (PCI). Therefore, this study aimed to determine acute and sub-acute ST incidence, predictors, and outcomes after primary PCI.
Rajesh Kumar   +9 more
doaj   +1 more source

Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire

open access: yesHealth and Quality of Life Outcomes, 2020
Purpose The present study evaluated how heart failure (HF) negatively impacts health-related quality of life (HRQoL) in hypertrophic cardiomyopathy (HCM) patients and explored the major clinical determinants associated with HRQoL impairment in this ...
Razvan Capota   +6 more
doaj   +1 more source

Lipoprotein(a) in Cardiovascular Diseases [PDF]

open access: yesBioMed Research International, 2013
Lipoprotein(a) (Lp(a)) is an LDL-like molecule consisting of an apolipoprotein B-100 (apo(B-100)) particle attached by a disulphide bridge to apo(a). Many observations have pointed out that Lp(a) levels may be a risk factor for cardiovascular diseases.
Malaguarnera M   +9 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy